Pulling and braking of ‘ancient motor’ in cell division | Tech…
Researchers at Dartmouth College have revealed how a key protein functions during the millions of cell divisions that occur in the human body each minute. The…
Browsing Tag
science
Syneos Health to make secondary stock offering of 6M shares | Tech Science
Syneos Health, a combo CRO/CCO, said it plans to make a secondary stock offering of 6 million shares priced to the public at $50.15 per share.
The company…
Vote for Gene Editing Panel at 2019 SXSW | Tech Science
Vote for “Gene Editing and The Future of Food and Agriculture” panel at the 2019 SXSW Conference and Festival in Austin, TX, March 8-17,…
Data science secrets in finance and media | Top Stories
Video: Data science and machine learning in marketing, media, and finance
Data is the…
U.K. commits to adopt EU trial regulation, minimize divergence after Brexit…
The U.K. regulatory agency has detailed how it expects Brexit to affect its clinical trial regulations. Officials reiterated their intent for the U.K. to…
Akouos raises $50M to take hearing loss gene therapy into humans | Tech…
Akouos has raised $50 million to take a gene therapy treatment for hearing loss into the clinic. The Boston-based biotech unveiled the series A round alongside…
Boehringer Ingelheim lands option on cystic fibrosis gene therapy | Tech…
Boehringer Ingelheim has secured the option to license a cystic fibrosis gene therapy. The agreement will see Boehringer work with British academics and Oxford…
Regeneron, Bluebird ink anti-cancer cell therapy pact | Tech Science
Regeneron and Bluebird bio have teamed up to develop anti-cancer cell therapies. The collaboration combines Regeneron’s antibody expertise with Bluebird’s cell…
Pain Therapeutics hit with yet another CRL, plots ‘reorganization,’…
With little surprise, Pain Therapeutics has been hit with a complete response letter from the FDA for Remoxy ER, its extended-release, capsule gel form of the…
Merck, HitGen expand DNA library screening collaboration | Tech Science
Merck and HitGen have upsized their licensing agreement into a full-fledged, multiyear drug discovery collaboration, with plans to screen DNA-encoded libraries…